0.15
+0.003(+2.00%)
Currency In USD
| Previous Close | 0.15 |
| Open | 0.13 |
| Day High | 0.15 |
| Day Low | 0.13 |
| 52-Week High | 3.96 |
| 52-Week Low | 0.12 |
| Volume | 23,336 |
| Average Volume | 4.41M |
| Market Cap | 1.21M |
| PE | -0.08 |
| EPS | -1.94 |
| Moving Average 50 Days | 0.43 |
| Moving Average 200 Days | 0.87 |
| Change | 0 |
If you invested $1000 in ZyVersa Therapeutics, Inc. (ZVSA) since IPO date, it would be worth $0.04 as of August 20, 2025 at a share price of $0.153. Whereas If you bought $1000 worth of ZyVersa Therapeutics, Inc. (ZVSA) shares 2 years ago, it would be worth $2.69 as of August 20, 2025 at a share price of $0.153.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ZyVersa Therapeutics Highlights Data Demonstrating a Critical Need for Therapies to Address Kidney Lipotoxicity to Alleviate Diabetic Kidney Disease (DKD) and Its Progression
GlobeNewswire Inc.
Aug 14, 2025 11:55 AM GMT
Data show that diabetes-associated metabolic issues lead to kidney lipid accumulation, resulting in inflammation and fibrosis that cause progressive kidney damage and disease progression.Earlier data by Kanbay et al (Eur J Clin Invest. 2022) demonstr
ZyVersa Therapeutics CEO Issues Mid-year Shareholder Letter Highlighting Recent Corporate Developments and R&D Progress
GlobeNewswire Inc.
Jul 21, 2025 11:55 AM GMT
WESTON, Fla., July 21, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with renal and inflammatory disease
ZyVersa Therapeutics Announces a Warrant Inducement Transaction for $2.0 Million in Gross Proceeds
GlobeNewswire Inc.
Jul 08, 2025 4:30 PM GMT
WESTON, Fla., July 08, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with renal and inflammatory disease